United Therapeutics Corp
Held by 14 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 91307C102 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns UTHR?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns UTHR? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value | % of their portfolio | QoQ ↓ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 2 | Norges Bank | Norges Bank Investment Management | 694.75K | $376.44M | 0.0% | — | — | — | — |
| 1 | Jim Simons | Renaissance Technologies | 1.71M | $925.85M | 1.3% | Reduced | -78.3K | -4.4% | -$42.41M |
| 5 | Ken Griffin | Citadel Advisors | 304.69K | $165.09M | 0.1% | Reduced | -56.0K | -15.5% | -$30.32M |
| 6 | LSV Asset Management | LSV Asset Management | 268.37K | $145.41M | 0.3% | Reduced | -130.3K | -32.7% | -$70.60M |
| 9 | Ken Fisher | Fisher Asset Management | 33.84K | $18.33M | 0.0% | Reduced | -568 | -1.7% | -$307.76K |
| 10 | Two Sigma | Two Sigma Investments | 12.61K | $6.83M | 0.0% | Reduced | -15.2K | -54.6% | -$8.22M |
| 12 | Jeremy Grantham | GMO | 3.28K | $1.78M | 0.0% | Reduced | -175 | -5.1% | -$94.82K |
| 14 | Fred Alger | Fred Alger Management | 1.63K | $882.64K | 0.0% | Reduced | -2.9K | -64.0% | -$1.57M |
| 13 | Bridgeway | Bridgeway Capital Management | 2.62K | $1.42M | 0.0% | Held | 0 | 0.0% | $0 |
| 3 | Baillie Gifford | Baillie Gifford & Co | 467.21K | $253.15M | 0.2% | Added | +39.1K | +9.1% | +$21.18M |
| 4 | Israel Englander | Millennium Management | 409.07K | $221.65M | 0.1% | Added | +255.7K | +166.7% | +$138.55M |
| 7 | Steve Cohen | Point72 Asset Management | 201.16K | $108.99M | 0.2% | Added | +51.9K | +34.7% | +$28.10M |
| 8 | Ray Dalio | Bridgewater Associates | 111.33K | $60.32M | 0.2% | Added | +157 | +0.1% | +$85.07K |
| 11 | Charles Brandes | Brandes Investment Partners | 4.74K | $2.57M | 0.0% | Added | +461 | +10.8% | +$249.78K |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| David Shaw | D.E. Shaw & Co. | -99.1K | $58.77M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lisa McClain Politician | Oct 30, 2025 | UTHR | United Therapeutics Corporation - Common Stock (UTHR) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | UTHR | United Therapeutics Corporation - Common Stock (UTHR) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 31, 2025 | UTHR | United Therapeutics Corporation - Common Stock (UTHR) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 21 days | PTR ↗ |
| Lisa McClain Politician | Jun 11, 2025 | UTHR | United Therapeutics Corporation - Common Stock (UTHR) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Aug 13, 2025 | 63 days Late | PTR ↗ |
| Michael T. McCaul Politician | Jan 5, 2025 | UTHR | UNITED THERAPEUTICS CORP scanned | Sale | $50,001 - $100,000 | Est. $75,000 (midpoint of reported range $50,001–$100,000) | Spouse | — | Jan 15, 2025 | 10 days | PTR ↗ |
| Michael T. McCaul Politician | Dec 5, 2024 | UTHR | UNITED THERAPEUTICS CORP scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Dec 16, 2024 | 11 days | PTR ↗ |
| Michael T. McCaul Politician | Dec 5, 2024 | UTHR | UNITED THERAPEUTICS CORP scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Dec 16, 2024 | 11 days | PTR ↗ |